NLRP3 and schizophrenia: This raises the possibility that SARS-CoV-2 may enhance NLRP3-dependent pyroptosis through the upregulation of HERV-W env, implying that HERV-W env could serve as a potential therapeutic target for both schizophrenia and inflammatory respiratory diseases caused by SARS-CoV-2.